Dr. Jay H. Traverse III, MD

Dr. Traverse practices at Abbott Northwestern Hospital in Minneapolis, Minnesota, part of Sutter Health.

Dr. Traverse's NPI, 1306807458, was assigned on March 29, 2006. Dr. Traverse graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University in 1989. Dr. Traverse holds Minnesota license 34287.

Dr. Traverse's primary practice is Abbott Northwestern Hospital, at 800 East 28th Street, Minneapolis, MN 55407 in Hennepin County. The practice phone is (612) 863-4000.

Dr. Traverse's primary practice is Abbott Northwestern Hospital in Minneapolis, Minnesota, part of Sutter Health. Dr. Traverse is also affiliated with Ridgeview Medical Center. The medical group on file is Buffalo Hospital. Dmand AI also links Dr. Traverse to 2 more hospitals, 2 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Traverse practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Traverse's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Traverse is licensed in Minnesota.

CMS data shows 422 Medicare services from Dr. Traverse across 13 procedure codes in 2024, for 294 Medicare patients. Medicare paid $46,154 for them.

CMS counts 294 Medicare patients who saw Dr. Traverse in 2024. The largest group is 75 to 84, with 109 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Traverse's median patient age at 72, with 33% women.

In 2024, Dr. Traverse wrote 1,308 Medicare Part D claims for 235 patients. 88% of them were for generic drugs. CMS names the drug for 1,174 of them, across 25 drugs with 11 or more claims each, at $134,665 in total drug cost. In 2023, CMS named 1,119 claims across 27 drugs.

Dr. Traverse accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Traverse as offering telehealth. CMS counts 16 procedures of coronary angioplasty and stenting by Dr. Traverse, more than 42% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 92 papers to Dr. Traverse, published from 2013 to 2025. 2020 was the busiest year, with 11. The most frequent topics are Percutaneous Coronary Intervention, Myocardial Infarction and Ventricular Function, Left. Dr. Traverse has published most often in Catheter Cardiovasc Interv. Dr. Traverse's most frequent co-authors are Timothy D. Henry, MD, Carl J. Pepine, MD and Ivan J. Chavez, MD.

Dmand AI links Dr. Traverse to 3 clinical trials. Conditions studied include Chronic Limb-Threatening Ischemia, Coronary Artery Disease and Coronary Disease. Abbott Medical Devices sponsors the most, 2. Open Payments lists research payments to Dr. Traverse that name 3 trials.

CMS Open Payments shows 290 general payments to Dr. Traverse from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 93% of the total. Abbott Laboratories paid the most, $174,828. It also lists 36 research payments totaling $29,452 from 2016 to 2019, naming 3 clinical trials.

Dr. Traverse graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University in 1989.